Siew Tim Lai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Siew Tim Lai has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Ching Soong Khoo
Department of Medicine, Faculty of Medicine Universiti Kebangsaan Malaysia Kuala Lumpur Malaysia
2 shared publications - Cyena Chaza Anak Kutiang
MOH Holdings Pte Ltd Singapore
2 shared publications - Hui Jan Tan
Department of Medicine, Faculty of Medicine Universiti Kebangsaan Malaysia Kuala Lumpur Malaysia
2 shared publications - Juen Kiem Tan
Department of Medicine, Faculty of Medicine Universiti Kebangsaan Malaysia Kuala Lumpur Malaysia
2 shared publications - Kah Hui Yap
Department of Psychological Medicine, Faculty of Medicine Universiti Malaya Kuala Lumpur Malaysia
2 shared publications - Marjorie Jia Yi Ong
MOH Holdings Pte Ltd Singapore
2 shared publications
Latest Publications
A systematic review on mental health issues in adults with newly diagnosed epilepsy
Objective: Mental health conditions often co‐occur with epilepsy, causing burden and stress beyond seizures. Some of these conditions can emerge early and even predate the onset of seizure and/or epilepsy diagnosis. This systematic review synthesizes evidence on mental health outcomes in adults with newly diagnosed epilepsy (NDE). Methods: A systematic literature search was conducted up to September 2025. All quantitative studies were included without restriction to study types. Mental health outcomes included a board range of mood, anxiety, quality of life, and stigma as primary or secondary outcome measures that were assessed and reported using validated scales. Standard methodological procedures for literature search, data collection, assessment of risk of bias, and analysis were used based on the Preferred Reporting Items for Systematic reviews and Meta‐Analyses (PRISMA) 2020 guideline. Results: Twenty‐one publications ( n = 4728 adults) across 10 countries were included, of which 12 (57%) showed low risk of bias. Methodological heterogeneity precluded meta‐analysis. Depressive and anxiety symptoms were the most frequently assessed, with 11%–50% (data from 14 papers) and 25%–35% (11 papers) of NDE screened positive on validated screening tools, respectively. Structured diagnostic tools in two papers revealed clinical depression in 2.9%–13.3% and anxiety/neurotic disorders in approximately one‐quarter of NDE. The prevalence of perceived stigma was reported in 25%–53% of NDE; quality of life was impaired by mood symptom, stigma, and role disability. Significance: Mental health conditions impose a substantial early burden among adults with NDE. Managing this burden requires integrating routine screening into early care pathways as a first step, coupled with a tiered psychiatric diagnostic process. Psychoeducation on these mental health risks should also be integrated into epilepsy care to promote awareness and access to services.
A systematic review on mental health issues in adults with newly diagnosed epilepsy
Objective: Mental health conditions often co‐occur with epilepsy, causing burden and stress beyond seizures. Some of these conditions can emerge early and even predate the onset of seizure and/or epilepsy diagnosis. This systematic review synthesizes evidence on mental health outcomes in adults with newly diagnosed epilepsy (NDE). Methods: A systematic literature search was conducted up to September 2025. All quantitative studies were included without restriction to study types. Mental health outcomes included a board range of mood, anxiety, quality of life, and stigma as primary or secondary outcome measures that were assessed and reported using validated scales. Standard methodological procedures for literature search, data collection, assessment of risk of bias, and analysis were used based on the Preferred Reporting Items for Systematic reviews and Meta‐Analyses (PRISMA) 2020 guideline. Results: Twenty‐one publications ( n = 4728 adults) across 10 countries were included, of which 12 (57%) showed low risk of bias. Methodological heterogeneity precluded meta‐analysis. Depressive and anxiety symptoms were the most frequently assessed, with 11%–50% (data from 14 papers) and 25%–35% (11 papers) of NDE screened positive on validated screening tools, respectively. Structured diagnostic tools in two papers revealed clinical depression in 2.9%–13.3% and anxiety/neurotic disorders in approximately one‐quarter of NDE. The prevalence of perceived stigma was reported in 25%–53% of NDE; quality of life was impaired by mood symptom, stigma, and role disability. Significance: Mental health conditions impose a substantial early burden among adults with NDE. Managing this burden requires integrating routine screening into early care pathways as a first step, coupled with a tiered psychiatric diagnostic process. Psychoeducation on these mental health risks should also be integrated into epilepsy care to promote awareness and access to services.
- 27 March 2026
- Published by Wiley in Epileptic Disorders
- Vol. 28 (3) , 638-660
Music‐based intervention as an adjunctive therapy in people with epilepsy: A scoping review
Epilepsy is a major neurological disorder that affects individuals across all age groups and can significantly impair their quality of life. Although pharmacological treatments are available, there remains a need for complementary non‐pharmacological lifestyle interventions. Music‐based intervention (MBI) is a possible option, as it is non‐invasive, cost‐effective, and easily implemented. This scoping review aims to identify and describe MBIs used in the management of epilepsy. A systematic search was conducted from April 9 to June 10, 2025, using two electronic databases: Ovid Medline and Scopus. The protocol was prospectively registered with the Research Ethics Committee of Universiti Kebangsaan Malaysia (FF‐2025‐173) and PROSPERO (CRD420251119617). Of the 3977 articles identified, 21 studies investigating MBIs for epilepsy met the inclusion criteria. Ten studies were rated as having a high risk of bias based on the Cochrane risk‐of‐bias assessment tool. The remaining studies provided Class II evidence according to both the GRADE and OCEBM frameworks. Most studies used passive listening of pre‐recorded Mozart K.448 for intervention. Overall, MBIs were assigned a Level C recommendation for epilepsy. MBIs for epilepsy require further investigations with robust study designs and a standardized protocol. Heterogeneous study designs and small samples are likely barriers to meaningful clinical translation. Therefore, the rating of recommendations only serves as a point of reference. Future avenues include live performance and reminiscence elements.
- 27 March 2026
- Published by Wiley in Epileptic Disorders
- Vol. 28 (3) , 638-660
Music‐based intervention as an adjunctive therapy in people with epilepsy: A scoping review
Epilepsy is a major neurological disorder that affects individuals across all age groups and can significantly impair their quality of life. Although pharmacological treatments are available, there remains a need for complementary non‐pharmacological lifestyle interventions. Music‐based intervention (MBI) is a possible option, as it is non‐invasive, cost‐effective, and easily implemented. This scoping review aims to identify and describe MBIs used in the management of epilepsy. A systematic search was conducted from April 9 to June 10, 2025, using two electronic databases: Ovid Medline and Scopus. The protocol was prospectively registered with the Research Ethics Committee of Universiti Kebangsaan Malaysia (FF‐2025‐173) and PROSPERO (CRD420251119617). Of the 3977 articles identified, 21 studies investigating MBIs for epilepsy met the inclusion criteria. Ten studies were rated as having a high risk of bias based on the Cochrane risk‐of‐bias assessment tool. The remaining studies provided Class II evidence according to both the GRADE and OCEBM frameworks. Most studies used passive listening of pre‐recorded Mozart K.448 for intervention. Overall, MBIs were assigned a Level C recommendation for epilepsy. MBIs for epilepsy require further investigations with robust study designs and a standardized protocol. Heterogeneous study designs and small samples are likely barriers to meaningful clinical translation. Therefore, the rating of recommendations only serves as a point of reference. Future avenues include live performance and reminiscence elements.
- 27 September 2023
- Published by Elsevier in Epilepsy & Behavior
- Vol. 148, 109455
Feasibility of psychological screening in a tertiary epilepsy clinic
- 27 September 2023
- Published by Elsevier in Epilepsy & Behavior
- Vol. 148, 109455
Feasibility of psychological screening in a tertiary epilepsy clinic